Legal & General Group
CAI

Legal & General Group’s Caris Life Sciences CAI Stock Holding History

Legal & General Group’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
32,070
+3,289
+11% +$58.9K ﹤0.01% 2353
2026
Q1 		$515K Buy
28,781
+21,900
+318% +$479K ﹤0.01% 2342
2025
Q4 		$186K Buy
6,881
+4,584
+200% +$129K ﹤0.01% 2589
2025
Q3 		$69.4K Buy
2,297
+1,297
+130% +$41.4K ﹤0.01% 2674
2025
Q2 		$26.7K Buy
+1,000
New +$26.9K ﹤0.01% 2893

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Legal & General Group's CAI Position: Q2 2026 in Review

Legal & General Group increased its Caris Life Sciences (CAI) stake by 11% in Q2 2026, buying an estimated $58.9K and bringing the position to 32,070 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Legal & General Group first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Legal & General Group held 32,070 shares of Caris Life Sciences worth $571K as of Q2 2026.
  • Legal & General Group bought 3,289 Caris Life Sciences shares in Q2 2026, an estimated $58.9K.
  • Caris Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2353 holding.
  • Legal & General Group first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.